Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT04506372 Terminated - Surgery Clinical Trials

Management of Angiotensin Inhibitors During the Perioperative Period

AIPOP
Start date: September 11, 2020
Phase: N/A
Study type: Interventional

This is a multicenter randomized clinical trial to determine the effect of continuation versus withdrawal of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) in the perioperative period on postoperative complications.

NCT ID: NCT04467879 Terminated - Clinical trials for Hypertension, Systolic

A Pivotal Study To Evaluate The Effectiveness of Isometric Handgrip Therapy In Prehypertensive And Hypertensive Patients

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

This is a double-blind, sham-controlled clinical trial assessing the effectiveness of personalized isometric handgrip device therapy. Approximately 230 patients who present with a Systolic Blood Pressure reading of ≤ 149mmHg and who have not taken any antihypertensive medication for more than 30 days will be enrolled.

NCT ID: NCT04435782 Terminated - Clinical trials for Pulmonary Arterial Hypertension

A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging

RESTORE
Start date: July 7, 2021
Phase: Phase 4
Study type: Interventional

The purpose of the study is to assess the effects of selexipag on right ventricular (RV) function in participants with Pulmonary arterial hypertension (PAH).

NCT ID: NCT04402385 Terminated - Pre-Eclampsia Clinical Trials

Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)

Start date: August 6, 2020
Phase: Phase 2
Study type: Interventional

To determine if low dose aspirin reduces the incidence of hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome) in pregnant women with stage 1 hypertension and elevated blood pressure.

NCT ID: NCT04349124 Terminated - Clinical trials for Hypertension in Pregnancy

Persistent Postpartum Hypertension Pilot Trial

Start date: August 25, 2020
Phase: Phase 4
Study type: Interventional

This study is a pilot, open-label, randomized controlled trial of postpartum women with hypertensive disorders pregnancy and persistent non-severe blood pressure. The purpose of the study to provide data that may provide guidance regarding blood pressure management of patients with non-severe postpartum hypertension. There are limited guidelines for best practice with persistent, non-severe hypertension, and treatment in this situation is usually at the provider's discretion.

NCT ID: NCT04343235 Terminated - Clinical trials for Hypertension, Pregnancy-Induced

Postpartum Management of Gestational Hypertensive Disorders Using Furosemide

Start date: May 1, 2020
Phase: Phase 4
Study type: Interventional

- The main purpose of this study is to learn if incorporating a loop diuretic such as furosemide along with labetalol in the routine management of postpartum gestational hypertensive disorders could lower the need for additional anti-hypertensive agents to control blood pressures, improve blood pressures (as measured by systolic blood pressure, diastolic blood pressure and mean arterial blood pressures), shorten hospital stays and decrease readmissions for patients with gestational hypertensive disorders. - Based on a study by Veena et al1, there is reason to believe that the addition of furosemide to other anti-hypertensives may help decrease the need to add or increase the dose of medication to control blood pressures. There may be potential to shorten hospital stays and decrease readmissions, as well. Collecting data will be done using a prospective, randomized 1:1 controlled study assigning postpartum patients with a gestational hypertensive diagnosis to either labetalol alone or labetalol plus furosemide. - The study will be performed in the postpartum wing of Miami Valley Hospital Main Campus and would use patients who have consented to participate in the study with enrollees coming from the OB Staff population.

NCT ID: NCT04329312 Terminated - Clinical trials for Pulmonary Hypertension

Differential Diagnosis of Pulmonary Hypertension With Automated Image Analysis

Start date: June 15, 2020
Phase:
Study type: Observational

The aim of the study is to determine relevant morphologic parameters of the lung vasculature for the differentiation between different groups of patients with pulmonary hypertension (PH) by thoracic computer tomography (CT). In this pilot study patients undergoing right heart catheterization will be investigated by thoracic CT and special software to determine morphologic readouts. The investigators expect that using this non-invasive method, parameters relevant for the differentiation of the patients with PH can be determined.

NCT ID: NCT04327934 Terminated - Hypertension Clinical Trials

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

Start date: December 1, 2017
Phase: Early Phase 1
Study type: Interventional

Women with androgen excess polycystic ovary syndrome (AE-PCOS) leads to hypertension.

NCT ID: NCT04271475 Terminated - Clinical trials for Chronic Thromboembolic Pulmonary Hypertension

A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

MACiTEPH
Start date: July 7, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the effect of macitentan 75 mg versus placebo on exercise capacity at Week 28 in participants with chronic thromboembolic pulmonary hypertension (CTEPH).

NCT ID: NCT04229667 Terminated - Hypertension Clinical Trials

Community Models for Hypertension and Diabetes Care for Refugees

Start date: January 31, 2020
Phase:
Study type: Observational

The project will investigate and improve a community health worker (CHW) based model for non-communicable disease (NCD) care in a humanitarian emergency.